新药研发中的me-too,me-better,me-new  

Me-too drug,me-better drug and me-new drug in drug R&D

作　　者：郑玉果[1] 陈代杰[1] 朱宝泉[1] 

机构地区：[1]上海医药工业研究院,上海200040

出　　处：《中国新药杂志》2009年第3期190-192,198,共4页Chinese Journal of New Drugs

摘　　要：文中根据作者对我国新药研发的认识和理解,提出了新药研发过程中me-too,me-better和me-new类新药的概念,并对新药研发过程中的这3类创新活动之间的关系、新药研发的创新程度与经济效益的关系,以及目前我国新药研发的途径选择做了简要的论述。In this paper, we proposed the concepts of me-too drug, me-better drug and me-new drug according to our understanding of drug R＆D in China. We described the relations among me-too, me-better and me- new drugs, and the relation between innovative degree and economic returns during drug R＆D as well as the route for drug R＆D in China.

关 键 词：新药研发 模仿药物 模仿创新药物 原始创新药物 

分 类 号：R95[医药卫生—药学]